Chemed Corp. (CHE)

$513.65

-0.81

(-0.16%)▲

Market is closed - opens 7 PM, 27 Sep 2023

Insights on Chemed Corp.

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 560.15M → 553.81M (in $), with an average decrease of 1.1% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 62.12M → 53.37M (in $), with an average decrease of 7.1% per quarter

  • Vs FMS

    In the last 1 year, Fresenius Medical Care Ag & Co. Kgaa has given 58.6% return, outperforming this stock by 43.1%

Performance

  • $507.52
    $515.45
    $513.65
    downward going graph

    1.19%

    Downside

    Day's Volatility :1.54%

    Upside

    0.35%

    downward going graph
  • $428.54
    $574.21
    $513.65
    downward going graph

    16.57%

    Downside

    52 Weeks Volatility :25.37%

    Upside

    10.55%

    downward going graph

Returns

PeriodChemed Corp.Sector (Health Care)Index (Russel 2000)
3 Months
-5.35%
-0.9%
0.0%
6 Months
-2.42%
1.5%
1.0%
1 Year
15.55%
7.1%
6.4%
3 Years
6.93%
25.9%
19.9%

Highlights

Market Capitalization
7.8B
Book Value
$63.42
Dividend Share
1.52
Dividend Yield
0.31%
Earnings Per Share (EPS)
15.0
PE Ratio
34.3
PEG Ratio
2.57
Wall Street Target Price
592.0
Profit Margin
10.36%
Operating Margin TTM
14.09%
Return On Assets TTM
13.67%
Return On Equity TTM
27.67%
Revenue TTM
2.2B
Revenue Per Share TTM
146.24
Quarterly Revenue Growth YOY
4.2%
Gross Profit TTM
765.1M
EBITDA
361.9M
Diluted Eps TTM
15.0
Quarterly Earnings Growth YOY
-0.2
EPS Estimate Current Year
19.98
EPS Estimate Next Year
22.32
EPS Estimate Current Quarter
5.09
EPS Estimate Next Quarter
5.18

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Chemed Corp.(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 15.25%

Current $513.65
Target $592.00

Company Financials

FY17Y/Y Change
Revenue
1.7B
↑ 5.7%
Net Income
98.2M
↓ 9.72%
Net Profit Margin
5.89%
↓ 1.01%
FY18Y/Y Change
Revenue
1.8B
↑ 6.96%
Net Income
205.5M
↑ 109.36%
Net Profit Margin
11.53%
↑ 5.64%
FY19Y/Y Change
Revenue
1.9B
↑ 8.75%
Net Income
219.9M
↑ 7.0%
Net Profit Margin
11.34%
↓ 0.19%
FY20Y/Y Change
Revenue
2.1B
↑ 7.27%
Net Income
319.5M
↑ 45.26%
Net Profit Margin
15.36%
↑ 4.02%
FY21Y/Y Change
Revenue
2.1B
↑ 2.87%
Net Income
268.6M
↓ 15.94%
Net Profit Margin
12.55%
↓ 2.81%
FY22Y/Y Change
Revenue
2.1B
↓ 0.2%
Net Income
249.6M
↓ 7.05%
Net Profit Margin
11.69%
↓ 0.86%
Q1 FY22Q/Q Change
Revenue
530.5M
↓ 1.93%
Net Income
64.2M
↓ 14.01%
Net Profit Margin
12.09%
↓ 1.7%
Q2 FY22Q/Q Change
Revenue
531.3M
↑ 0.14%
Net Income
66.5M
↑ 3.56%
Net Profit Margin
12.51%
↑ 0.42%
Q3 FY22Q/Q Change
Revenue
526.5M
↓ 0.91%
Net Income
56.9M
↓ 14.42%
Net Profit Margin
10.8%
↓ 1.71%
Q4 FY22Q/Q Change
Revenue
546.7M
↑ 3.83%
Net Income
62.1M
↑ 9.24%
Net Profit Margin
11.36%
↑ 0.56%
Q1 FY23Q/Q Change
Revenue
560.2M
↑ 2.47%
Net Income
54.1M
↓ 12.89%
Net Profit Margin
9.66%
↓ 1.7%
Q2 FY23Q/Q Change
Revenue
553.8M
↓ 1.13%
Net Income
53.4M
↓ 1.37%
Net Profit Margin
9.64%
↓ 0.02%
FY17Y/Y Change
Total Assets
920.0M
↑ 4.54%
Total Liabilities
379.7M
↑ 6.66%
FY18Y/Y Change
Total Assets
975.5M
↑ 6.03%
Total Liabilities
384.2M
↑ 1.19%
FY19Y/Y Change
Total Assets
1.3B
↑ 30.01%
Total Liabilities
541.7M
↑ 41.0%
FY20Y/Y Change
Total Assets
1.4B
↑ 13.14%
Total Liabilities
533.7M
↓ 1.48%
FY21Y/Y Change
Total Assets
1.3B
↓ 6.42%
Total Liabilities
719.5M
↑ 34.8%
FY22Y/Y Change
Total Assets
1.4B
↑ 7.39%
Total Liabilities
643.3M
↓ 10.58%
Q1 FY22Q/Q Change
Total Assets
1.3B
↓ 2.75%
Total Liabilities
639.1M
↓ 11.17%
Q2 FY22Q/Q Change
Total Assets
1.3B
↑ 0.55%
Total Liabilities
628.0M
↓ 1.73%
Q3 FY22Q/Q Change
Total Assets
1.4B
↑ 3.29%
Total Liabilities
634.8M
↑ 1.08%
Q4 FY22Q/Q Change
Total Assets
1.4B
↑ 6.33%
Total Liabilities
643.3M
↑ 1.34%
Q1 FY23Q/Q Change
Total Assets
1.4B
↓ 0.75%
Total Liabilities
551.1M
↓ 14.33%
Q2 FY23Q/Q Change
Total Assets
1.5B
↑ 5.17%
Total Liabilities
553.1M
↑ 0.36%
FY17Y/Y Change
Operating Cash Flow
162.5M
↑ 20.02%
Investing Cash Flow
-67.6M
↑ 69.61%
Financing Cash Flow
-99.1M
↑ 4.35%
FY18Y/Y Change
Operating Cash Flow
287.1M
↑ 76.71%
Investing Cash Flow
-105.2M
↑ 55.64%
Financing Cash Flow
-188.2M
↑ 89.96%
FY19Y/Y Change
Operating Cash Flow
301.2M
↑ 4.91%
Investing Cash Flow
-190.8M
↑ 81.29%
Financing Cash Flow
-109.2M
↓ 42.0%
FY20Y/Y Change
Operating Cash Flow
489.3M
↑ 62.42%
Investing Cash Flow
-61.6M
↓ 67.73%
Financing Cash Flow
-271.2M
↑ 148.45%
FY21Y/Y Change
Operating Cash Flow
308.6M
↓ 36.93%
Investing Cash Flow
-57.8M
↓ 6.18%
Financing Cash Flow
-380.6M
↑ 40.34%
FY22Y/Y Change
Operating Cash Flow
309.9M
↑ 0.42%
Investing Cash Flow
-59.4M
↑ 2.85%
Financing Cash Flow
-209.3M
↓ 45.02%
Q1 FY22Q/Q Change
Operating Cash Flow
101.1M
↑ 59.02%
Investing Cash Flow
-13.9M
↓ 0.69%
Financing Cash Flow
-101.9M
↑ 124.53%
Q2 FY22Q/Q Change
Operating Cash Flow
56.6M
↓ 44.03%
Investing Cash Flow
-11.7M
↓ 16.21%
Financing Cash Flow
-53.4M
↓ 47.57%
Q3 FY22Q/Q Change
Operating Cash Flow
52.0M
↓ 8.06%
Investing Cash Flow
-14.3M
↑ 22.18%
Financing Cash Flow
-39.6M
↓ 25.87%
Q4 FY22Q/Q Change
Operating Cash Flow
309.9M
↑ 495.74%
Investing Cash Flow
-59.4M
↑ 316.01%
Financing Cash Flow
-209.3M
↑ 428.46%

Technicals Summary

Sell

Neutral

Buy

Chemed Corp. is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Chemed Corp.
Chemed Corp.
1.43%
-2.42%
15.55%
6.93%
60.93%
Fresenius Medical Care Ag & Co. Kgaa
Fresenius Medical Care Ag & Co. Kgaa
-8.7%
5.1%
58.65%
-48.25%
-57.86%
Hca Holdings, Inc.
Hca Holdings, Inc.
-10.48%
-2.34%
34.81%
104.73%
79.61%
Universal Health Services Inc.
Universal Health Services Inc.
-5.38%
1.79%
43.32%
20.53%
-0.38%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
-4.84%
24.02%
15.58%
13.23%
34.31%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Chemed Corp.
Chemed Corp.
34.3
34.3
2.57
19.98
0.28
0.14
0.0
63.42
Fresenius Medical Care Ag & Co. Kgaa
Fresenius Medical Care Ag & Co. Kgaa
20.88
20.88
1.06
2.0
0.05
0.03
0.03
23.05
Hca Holdings, Inc.
Hca Holdings, Inc.
12.58
12.58
1.37
18.44
0.21
0.11
0.01
-8.44
Universal Health Services Inc.
Universal Health Services Inc.
13.31
13.31
1.87
10.19
0.11
0.05
0.01
87.72
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
19.21
19.21
0.86
7.21
0.29
0.05
0.0
11.15
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Chemed Corp.
Chemed Corp.
Buy
$7.8B
60.93%
34.3
10.36%
Fresenius Medical Care Ag & Co. Kgaa
Fresenius Medical Care Ag & Co. Kgaa
Hold
$13.1B
-57.86%
20.88
3.04%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$69.2B
79.61%
12.58
9.32%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$8.9B
-0.38%
13.31
5.02%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$8.7B
34.31%
19.21
3.98%

Institutional Holdings

  • Vanguard Group Inc

    11.24%

  • BlackRock Inc

    9.39%

  • William Blair Investment Management, LLC

    3.72%

  • Kayne Anderson Rudnick Investment Management LLC

    3.43%

  • Neuberger Berman Group LLC

    3.37%

  • Durable Capital Partners LP

    3.03%

Corporate Announcements

  • Chemed Corp. Dividends March,2023

    In the quarter ending March,2023. Chemed Corp. has declared dividend of $0.38

    Read More

Company Information

chemed is a holding company. our wholly owned subsidiaries are vitas and roto-rooter services company. vitas is a healthcare company that specializes in hospice or end of life care for the terminally ill. roto-rooter is the nation's largest provider of plumbing and drain care services.

Organization
Chemed Corp.
Employees
14167
CEO
Mr. Kevin J. McNamara
Industry
Health Services

Discover More

FAQs